Crgw Holdings Limited

Crgw Holdings Limited is engaged in the fertility sector, providing a wide array of assisted reproductive technologies and supportive services for individuals and couples facing fertility challenges. Crgw Holdings Limited specializes in fertility treatments, offering services such as In Vitro Fertilization (IVF) and egg freezing. Founded in 2014, the company operates clinics in major urban centers across the UK, with an emphasis on diverse client groups. The founder's history is not specified, and there is no mention of any funding rounds or subsidiaries.

Crgw Holdings Limited provides a comprehensive range of fertility treatments and services, focusing primarily on assisted reproductive technologies such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), and Intracytoplasmic Sperm Injection (ICSI). The company addresses various fertility challenges faced by clients, including heterosexual couples, single individuals, same-sex couples, and transgender and non-binary persons. Additionally, their offerings include fertility preservation services—such as egg, sperm, and embryo freezing—as well as advanced genetic testing and embryology services, supporting clients in their fertility journeys. Crgw Holdings Limited generates revenue primarily through direct-to-consumer transactions for its fertility treatments and services.

Clients engage with the company for various fertility solutions, structured as one-time payments or packages covering multiple procedures, with options for customized treatment plans. The revenue model also includes partnerships with healthcare providers and insurance companies, facilitating access to its services. Key offerings like IVF and egg freezing are priced based on the complexity and requirements of each case.